SCHEMBL15949451

SCHEMBL15949451

O=C(c1ccccc1)N1CCc2cccc(C(=O)N3CC(N4CCN(C(=O)c5nccs5)CC4)C3)c2C1

nearest known ligand 0.54

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 17/20 0.54
FAAH O00519 1/20 0.46
SLC6A7 Q99884 1/20 0.41
F2 P00734 2/20 0.40
F10 P00742 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL912448 0.88 MGLL (0.51) MGLLFAAH
SCHEMBL953292 0.85 MGLL (0.47) MGLLFAAH
SCHEMBL7784149 0.85 MGLL (0.66) MGLLFAAHSLC6A7
SCHEMBL15958970 0.85 MGLL (0.51) MGLLFAAH
SCHEMBL3779972 0.84 MGLL (0.60) MGLLFAAH
SCHEMBL6840305 0.81 MGLL (0.50) MGLLFAAH
SCHEMBL915604 0.81 MGLL (0.64) MGLLFAAHSLC6A7
SCHEMBL911408 0.79 MGLL (0.69) MGLLFAAHSLC6A7
SCHEMBL911279 0.79 MGLL (0.69) MGLLFAAHSLC6A7
SCHEMBL699681 0.78 MGLL (0.59) MGLLFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421823-B1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2015-01-14 EP disclosed
EP-2421825-B9 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-08-20 EP disclosed
EP-2421825-B1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2014-01-01 EP disclosed